Harrow Inc (HROW)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt HROW? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Harrow Inc Stock (HROW) Company Profile

Healthcare (1111)

615.733.4731

1A BURTON HILLS BLVD, NASHVILLE, CA

Nächster Verdiensttermin

Neueste SEC-Einreichungen

HROW's Discussions on Twitter

Compare HROW vs TAK, ZTS, HLN, TEVA, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
HROW Harrow Inc	47.69	1.75B	154.15M	-33.58M	-20.74M	-0.96
TAK Takeda Pharmaceutical Co Adr	18.46	58.03B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	126.65	55.37B	9.40B	2.65B	2.24B	5.935
HLN Haleon Plc Adr	11.20	49.70B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	33.98	39.50B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	473.66	20.50B	3.13B	1.27B	1.12B	26.39

Harrow Inc Stock (HROW) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-07-11	Eingeleitet	Cantor Fitzgerald	Overweight
2025-06-12	Eingeleitet	BTIG Research	Buy
2025-06-10	Eingeleitet	William Blair	Outperform
2025-02-06	Eingeleitet	H.C. Wainwright	Buy
2024-12-04	Bestätigt	B. Riley Securities	Buy
2024-04-11	Eingeleitet	Craig Hallum	Buy
2022-09-08	Fortgesetzt	B. Riley Securities	Buy
2021-10-14	Fortgesetzt	B. Riley Securities	Buy
2021-09-24	Eingeleitet	Aegis Capital	Buy
2021-07-02	Eingeleitet	Ladenburg Thalmann	Buy

Alle ansehen

Harrow Inc Aktie (HROW) Neueste Nachrichten

Finanzdaten der Harrow Inc-Aktie (HROW)

Harrow Inc (HROW)

Harrow Inc Stock (HROW) Company Profile

Compare HROW vs TAK, ZTS, HLN, TEVA, UTHR

Harrow Inc Stock (HROW) Upgrades & Downgrades

Harrow Inc Aktie (HROW) Neueste Nachrichten

Loss Report: What are the future prospects of Harrow IncQuarterly Growth Report & Fast Gain Stock Tips - baoquankhu1.vn

Will Harrow Inc. stock attract more institutional investorsWeekly Trade Report & Weekly High Return Stock Forecasts - mfd.ru

Harrow, Inc. (HROW) Stock Analysis: A 48% Upside in the Promising Ophthalmic Pharmaceuticals Sector - DirectorsTalk Interviews

Is Harrow’s (HROW) Reaffirmed 2025 Guidance Quietly Redefining Its Ophthalmic Growth Strategy? - simplywall.st

Harrow Refocuses After ImprimisRx Exit As New CCO Takes Charge - Sahm

A Look At Harrow’s (HROW) Valuation As 2025 Guidance Is Reaffirmed And Regulatory Issues Clear - Yahoo Finance

New York State Common Retirement Fund Raises Stock Position in Harrow, Inc. $HROW - MarketBeat

B.Riley reiterates Buy rating on Harrow Health stock amid VEVYE growth - Investing.com

Harrow (NASDAQ:HROW) Downgraded by Zacks Research to "Hold" - MarketBeat

Growth Recap: Should I hold or sell Harrow Inc now2025 Breakouts & Breakdowns & AI Enhanced Trading Alerts - baoquankhu1.vn

Harrow Reaffirms FY2025 Revenue Growth Range Of 35% To 40%; Expands Sales Force - Nasdaq

Harrow Stock (+9.7%): Commercial Expansion Ignites Institutional Buying - Trefis

Strength Seen in Harrow (HROW): Can Its 9.7% Jump Turn into More Strength? - Nasdaq

Rival quits California market; OSRX steps in to keep eye meds flowing - stocktitan.net

How Harrow Health Inc. (HROW) Affects Rotational Strategy Timing - Stock Traders Daily

Harrow on track to double sales force, expand product reach By Investing.com - Investing.com Nigeria

OSRX Continues Support in California Market After Competitor Exit - Intellectia AI

Harrow (NASDAQ:HROW) Shares Gap UpShould You Buy? - MarketBeat

Harrow on track to double sales force, expand product reach - Investing.com

(HROW) Harrow Expects 2025 Revenue Range $270M$280M, vs. FactSet Est of $273.4M - marketscreener.com

Harrow Reaffirms 2025 Full-Year Revenue Guidance of $270–$280 Million, Marking Another Year of Strong Growth - marketscreener.com

Is Harrow Inc. attractive for institutional investors2025 Winners & Losers & Verified Momentum Stock Alerts - Mfd.ru

Harrow Becomes Oversold (HROW) - Nasdaq

Can Harrow Inc. be recession proofJuly 2025 Rallies & Daily Volume Surge Signals - mfd.ru

Risk Report: Is PMTV stock showing strong momentum2025 Price Targets & Low Volatility Stock Recommendations - baoquankhu1.vn

109,421 Shares in Harrow, Inc. $HROW Acquired by Blackhawk Capital Partners LLC - MarketBeat

Harrow, Inc. (NASDAQ:HROW) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Harrow: Revisiting This Eyecare Growth Story Ahead Of Q4 Update (NASDAQ:HROW) - Seeking Alpha

Harrow (NASDAQ:HROW) Shares Down 4.4%Time to Sell? - MarketBeat

Market Trends: Can Harrow Inc expand into new marketsJuly 2025 Drop Watch & AI Enhanced Execution Alerts - baoquankhu1.vn

Pharma News: Can Harrow Inc. be recession proofTrade Risk Assessment & Weekly High Return Stock Forecasts - baoquankhu1.vn

Investment Recap: Can OptimizeRx Corporation weather a recessionQuarterly Trade Review & Weekly Setup with ROI Potential - baoquankhu1.vn

Breakeven Is Near for Harrow, Inc. (NASDAQ:HROW) - Yahoo Finance

Assessing Harrow (HROW) Valuation After Its Shift To An Integrated U.S. Eye Care Pharma Platform - Sahm

LJI Wealth Management LLC Makes New Investment in Harrow, Inc. $HROW - MarketBeat

Opaleye management sells $711,814 worth of Harrow shares - MSN

Harrow announces leadership changes, Andrew Boll to serve as President and CFO - MSN

Harrow, Inc. (NASDAQ:HROW) Could Be Less Than A Year Away From Profitability - 富途资讯

Here's What Could Help Harrow (HROW) Maintain Its Recent Price Strength - sharewise.com

Harrow, Inc. (HROW): A Bull Case Theory - Finviz

Zacks Research Upgrades Harrow (NASDAQ:HROW) to "Strong-Buy" - MarketBeat

Gap Down: Can Harrow Inc maintain sales growthBull Run & Safe Capital Allocation Plans - baoquankhu1.vn

Harrow: Flirting With Missing 2025 Revised Guidance (NASDAQ:HROW) - Seeking Alpha

Value Recap: Will Harrow Inc benefit from geopolitical trendsWeekly Trend Summary & Weekly Momentum Stock Picks - baoquankhu1.vn

Responsive Playbooks and the HROW Inflection - Stock Traders Daily

Institution Moves: Is Harrow Inc stock attractive for ETFsTrade Analysis Summary & Low Drawdown Investment Strategies - moha.gov.vn

Harrow Stock (-8.3%): Major Holder Sale Near Highs Sparks Distribution - Trefis

Finanzdaten der Harrow Inc-Aktie (HROW)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie HROW